The science and practice of LSVT/LOUD: Neural plasticity - Principled approach to treating individuals with parkinson disease and other nuerological disorders

Seminars in Speech and Language

Volumn 27, Issue 4, 2006, Pages 283-299

  Fox, Cynthia M ^a,f   Raming, Lorraine O ^b,g,h   Ciucci, Michelle R ^b,c   Sapir, Shimon ^d   McFarland, David H ^e,i   Farley, Becky G ^f  

^a University of Arizona   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF HAIFA   (Israel)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g Denver Center for the Performing Arts   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

Neural plasticity; Parkinson's disease; Vocal loudness

Indexed keywords

ARTICLE; CEREBELLAR ATAXIA; CEREBRAL PALSY; CLINICAL PRACTICE; COMORBIDITY; DYSPHAGIA; FACIAL EXPRESSION; HEALTH CARE DELIVERY; HUMAN; LOUDNESS; MEDICAL RESEARCH; MOTOR CONTROL; MOTOR PERFORMANCE; MOTOR SYSTEM; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVE STIMULATION; NEUROLOGIC DISEASE; OCCUPATIONAL THERAPY; PARKINSON DISEASE; PATIENT CARE; PATIENT EDUCATION; PHYSIOTHERAPY; SELF CONCEPT; SHY DRAGER SYNDROME; SPEECH ARTICULATION; SPEECH DISORDER; SPEECH REHABILITATION; STROKE; SWALLOWING; TASK PERFORMANCE; TRAINING; TREATMENT OUTCOME; VERBAL COMMUNICATION;

DEGLUTITION DISORDERS; HUMANS; NERVOUS SYSTEM DISEASES; NEURONAL PLASTICITY; PARKINSON DISEASE; SPEECH ACOUSTICS; SPEECH THERAPY; TREATMENT OUTCOME; VOCAL CORDS; VOICE DISORDERS; VOICE TRAINING;

EID: 33845755899     PISSN: 07340478     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-955118     Document Type: Article

References (128)

1. Hartelius L, Svensson P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey. Folia Phoniatr Logop 1994;46:9-17
2. Ho A, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of people with Parkinson's disease. Behav Neurol 1998;11:131-137
3. Logemann J, Fisher H, Boshes B, Blonsky E. Frequency and concurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord 1978; 43:47-57
4. Pitcairn TK, Clemie S, Gray JM, Pentland B. Non-verbal cues in the self-presentation of parkinsonian patients. Br J Clin Psychol 1990; 29:177-184
5. Pitcairn TK, Clemie S, Gray JM, Pentland B. Non-verbal cues in the self-presentation of parkinsonian patients. Br J Clin Psychol 1990; 29:177-184
6. Logemann J, Blonsky R, Boshes B. Dysphagia in parkinsonism. JAMA 1975;231:69-70
7. Koller WC, Tse W. Unmet medical needs in Parkinson's disease. Neurology 2004;62(Suppl 1): S1-S8
8. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349(20):1925-1934
9. Olanow CW, Jankovic J. Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. Mov Disord 2005;20(Suppl 11): S3-10
10. Sapir S, Ramig LO, Countryman S, Fox C. Voice, speech, and swallowing disorders. In: Factor S, Weiner W, eds. Parkinson's Disease: Diagnosis and Clinical Management. 2nd ed. New York: Demos Medical Publishing; 2006:75-87
11. Wermuth L, Stenager EN, Stenager E, Boldsen J. Mortality in patients with Parkinson's disease. Acta Neurol Scand 1995;92:55-58
12. Tompkins P, Herman L. How many people in the U.S. have PD? Parkinson's Information Exchange; July 1998. Available at: http://www.parkinsons-information-exchange-network-online.com/ parkmail3a./1998c/msg00789.html. Accessed March 20, 1999
13. Ramig L, Countryman S, Thompson L, Horii Y. Comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hear Res 1995;38:1232-1251
14. Ramig LO, Sapir S, Countryman S, et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up. J Neurol Neurosurg Psychiatry 2001;71:493-498
15. Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls. Mov Disord 2001;16:79-83
16. Farley BG, Sherman S, Koshland GF. Shoulder muscle activity in Parkinson's disease during multijoint arm movements across a range of speeds. Exp Brain Res 2004;154:160-175
17. Hallett M, Khoshbin S. A physiological mechanism of bradykinesia. Brain 1980;103:301-314
18. Pfann KD, Buchman AS, Comella CL, Corcos DM. Control of movement distance in Parkinson's disease. Mov Disord 2001;16:1048-1065
19. Titze I. Vocal Fold Physiology: Frontiers in Basic Science. San Diego, CA: Singular; 1993
20. Fisher B, Petzinger G, Nixon K, et al. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 2004;77:378-390
21. Liepert J, Miltner W, Bauder H, et al. Motor cortex plasticity during constraint-induced movement therapy in stroke patients. Neurosci Lett 1998;250:5-8
22. Cabrejo L, Auzou P, Ozsancak C, Hannequin D. Speech therapy of dysarthria in Parkinson's disease. Presse Med 2003;32:1745-1751
23. Dias AE, Barbosa ER, Coracini K, Maia F, Marcolin MA, Fregni F. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease. Acta Neurol Scand 2006;113(2):92-99
24. NICENational Collaborating Centre for Chronic Conditions. Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. London: Royal College of Physicians; 2006
25. Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol 2004;3:547-556
26. Ramig LO, Countryman S, O'Brien C, Hoehn M, Thompson L. Intensive speech treatment for patients with Parkinson's disease: Short and long term comparison of two techniques. Neurology 1996;47:1496-1504
27. Smith M, Ramig LO, Dromey C, Perez K, Samandari R. Intensive voice treatment in Parkinson's disease: laryngostroboscopic ndings. J Voice 1995;9:453-459
28. Garren K, Brosovic G, Abaza M, Ramig L. Voice therapy and Parkinson disease: measures of vocal fold adduction. Paper presented at: the Voice Symposium; June 2000, Philadelphia, PA
29. Ramig L, Dromey C. Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson disease. J Speech Hear Res 1996;39:798-807
30. Huber J, Stathopoulos E, Ramig L, Lancaster S. Respiratory function and variability in individuals with Parkinson disease: pre and post Lee Silverman Voice Treatment (LSVT®). J Med Speech-Lang Pathol 2003;11:185-201
31. Ramig L, Sapir S, Baker K, et al. The "big picture" on the role of phonation in the treatment of individuals with motor speech disorders: or "What's up with loud?". Paper presented at: the Tenth Biennial Conference on Motor Speech; March 2000; San Antonio, TX
32. Baumgartner C, Sapir S, Ramig L. Voice quality changes following phonatory-respiratory effort Treatment (LSVT®) versus respiratory effort treatment for individuals with Parkinson disease. J Voice 2001;15:105-114
33. Countryman S, Hicks J, Ramig L, Smith M. Supraglottic hyperfunction in an individual with Parkinson disease: treatment outcome. Am J Speech Lang Pathol 1996;6:85-94
34. Dromey C, Ramig L, Johnson A. Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study. J Speech Hear Res 1995;38:751-763
35. Spielman J, Borod J, Ramig L. Effects of intensive voice treatment (LSVT) on facial expressiveness in Parkinson's disease: preliminary data. Cogn Behav Neurol 2003;16:177-188
36. El Sharkawi A, Ramig L, Logemann J, et al. Swallowing and voice effects of Lee Silverman Voice Treatment: a pilot study. J Neurol Neuropsychiatry Psychiatry 2002;72:31-36
37. Borod J, Koff E, Lorch M, Nicholas M. Channels of emotional communication in patients with unilateral brain damage. Arch Neurol 1985;42: 345-348
38. Borod J, Welkowitz J, Alpert M, et al. Parameters of emotional processing in neuropsychiatric disorders: conceptual issues and a battery of tests. J Commun Disord 1990;23:247-271
39. Canino E, Borod J, Madigan N, Tabert M, Schmid J. The development of procedures for rating posed emotional expressions across facial, prosodic, and lexical channels. Percept Mot Skills 1999;89:57-71
40. Ross E, Mesulam M. Dominant language functions of the right hemisphere? Arch Neurol 1979; 36:144-148
41. Porges S. Orienting in a defensive world: mammalian modifications of our evolutionary heritage. A polyvagal theory. Psychophysiology 1995;32: 301-318
42. Porges S. Emotion: an evolutionary by-product of the neural regulation of the autonomic nervous system. Ann NY Acad Sci 1997;807:62-77
43. Zald DH, Pardo JV. The functional neuroanatomy of voluntary swallowing. Ann Neurol 1999;46(3):281-286
44. Hamdy S, Mikulis DJ, Crawley A, et al. Cortical activation during human volitional swallowing: an event-related fMRI study. Am J Physiol 1999; 277(1 Pt 1):G219-G225
45. Liotti M, Ramig LO, Vogel D, et al. Hypophonia in Parkinson's disease. Neural correlates of voice treatment revealed by PET. Neurology 2003;60: 432-440
46. Kleinow J, Smith A, Ramig L. Speech stability in idiopathic Parkinson disease: effects of rate and loudness manipulations. J Speech Lang Hear Res 2001;44:1041-1051
47. Dromey C, Ramig L. Intentional changes in sound pressure level and rate: their impact on measures of respiration, phonation, and articulation. J Speech Lang Hear Res 1988;41:1003-1018
48. Will L, Spielman J, Ramig L. Stimulated or trained loudness: is there a difference and does it matter? Presented at: the Conference on Motor Speech Disorders; March 2006, Austin, TX
49. Schulman R. Articulatory dynamics of loud and normal speech. J Acoust Soc Am 1989;85:295-312
50. Narayana S, Vogel D, Brown S, et al. Mechanism of action of voice therapy in Parkinson's hypophonia - a PET study. Poster presented at: the 11th Annual Meeting of the Organization for Human Brain Mapping; 2005, Toronto, Ontario, Canada
51. Farley BG, Koshland GF. Training BIG to move faster: the application of the speed-amplitude relation as a rehabilitation strategy for people with Parkinson's disease. Exp Brain Res 2005;67:462-467
52. Fox C, Farley B, Ramig L. An integrated speech and physical therapy approach for Parkinson disease: Training Big and Loud. Abstract for paper presented at: the Biannual Conference on Motor Speech; March 2006, Austin, TX
53. Fox CM. Farley BG Learning Big and Loud™: an integrated rehabilitation approach to Parkinson's disease. Program No. 874.10, 2004 Abstract Viewer and Itinerary Planner. Washington, DC: Society for Neuroscience. Available at: www.sfn.scholarone.com/itin2004
54. Fox CM, Farley BG, Ramig LO, McFarland D. An integrated rehabilitation approach to Parkinson's disease: learning big and loud. Mov Disord 2005;20:S127
55. Countryman S, Ramig L. Effects of intensive voice therapy on voice deficits associated with bilateral thalamotomy in Parkinson's disease: a case study. J Med Speech-Lang Pathol 1993;1: 233-250
56. Countryman S, Ramig L, Pawlas A. Speech and voice deficits in Parkinsonian Plus syndromes: can they be treated? J Med Speech Lang Pathol 1994; 2:211-225
57. Sapir S, Spielman J, Countryman S, et al. Phonatory and articulatory changes in ataxic dysarthria following intensive voice therapy with the LSVT®: a single subject study. Am J Speech Lang Pathol 2003; 12:387-399
58. Sapir S, Pawlas A, Ramig L, Seeley E, Fox C, Corboy J. Effects of intensive phonatory-respiratory treatment (LSVT) on voice in individuals with multiple sclerosis. J Med Speech Lang Pathol 2001;9(2):35-45
59. Will LA, Fox C, Ramig LO. Intensive voice treatment for speech disorders following stroke. Poster presented at: the Motor Speech Disorders Conference; 2002, Williamsburg, VA
60. Ramig L, Gray S, Baker K, et al. The aging voice: a review, treatment data and familial and genetic perspectives. Folia Phoniatr Logop 2001;53(5): 252-265
61. Fox C. Intensive voice treatment for children with spastic cerebral palsy [Unpublished doctoral dissertation]. Tucson, AZ: University of Arizona; 2002
62. Petska J, Halpern A, Ramig L, Robinson T. LSVT® and children with Down syndrome: a pilot study. Poster session presented at: the 13th Biennial Conference on Motor Speech; March 2006, Austin, TX
63. Allen G. Segmental timing control in speech production. J Phonetics 1973;1:219-237
64. Gandour J, Dechongkit S, Ponglorpisit S, Khunadorn F. Speech timing at the sentence level in Thai after unilateral brain damage. Brain Lang 1994;46:419-438
65. McClean MD, Tasko SM. Association of orofacial with laryngeal and respiratory motor output during speech. Exp Brain Res 2002;146:481-489
66. Smith A, McFarland DH, Weber CM. Interactions between speech and finger movements: an exploration of the dynamic pattern perspective. J Speech Hear Res 1986;29:471-480
67. Ackermann H, Wildgruber D, Daum I, Grodd W. Does the cerebellum contribute to cognitive aspects of speech production? A functional magnetic resonance imaging (fMRI) study in humans. Neurosci Lett 1998;247:187-190
68. Hirano S, Kojima H, Naito Y, et al. Cortical speech processing mechanisms while vocalizing visually presented languages. Neuroreport 1996; 8:363-367
69. Ho AK, Iansek R, Bradshaw JL. Regulations of parkinsonian speech volume: the effect of interlocutor distance. J Neurol Neurosurg Psychiatry 1999;67:199-202
70. Ho AK, Bradshaw JL, Iansek T. Volume perception in parkinsonian speech. Mov Disord 2000;15:1125-1131
71. Jurgens U, Kirzinger A, von Cramon D. The effects of deep-reaching lesions in the cortical face area on phonation. A combined case report and experimental monkey study. Cortex 1982;18:125-130
72. Kitchen DM, Cheney DL, Seyfarth RM. Male chacma baboons (Papio hamadryas ursinus) discriminate loud call contests between rivals of different relative ranks. Anim Cogn 2005;8:1-6
73. Leinonen L, Laakso ML, Carlson S, Linnankoski I. Shared means and meanings in vocal expression of man and macaque. Logoped Phoniatr Vocol 2003;28:53-61
74. Tecumseh FW. The phonetic potential of non-human vocal tracts: comparative cineradiographic observations of vocalizing animals. Phonetica 2000;57:205-218
75. Ho AK, Iansek R, Bradshaw JL. Regulations of parkinsonian speech volume: the effect of interlocutor distance. J Neurol Neurosurg Psychiatry 1999;67:199-202
76. Ho AK, Bradshaw JL, Iansek R, Alfredson R. Speech volume regulation in Parkinson's disease: effects of implicit cues and explicit instructions. Neuropsychologia 1999;37:1453-1460
77. Jurgens U, von Cramon D. On the role of the anterior cingulate cortex in phonation: a case report. Brain Lang 1982;15:234-248
78. Meissner I, Sapir S, Kokmen E, Stein SD. The paramedian diencephalic syndrome: a dynamic phenomenon. Stroke 1987;18:380-385
79. Sapir S, Aronson AE. Clinician reliability in rating voice improvement after laryngeal nerve section for spastic dysphonia. Laryngoscope 1985; 95:200-202
80. Seyfarth RM, Cheney DL. Meaning and emotion in animal vocalizations. Ann NY Acad Sci 2003; 1000:32-55
81. Davis P, Zhang S, Winkworth A, Bandler R. Neural control of vocalization: respiratory and emotional influences. J Voice 1996;10:23-38
82. Jurgens U, Zwirner P. The role of the periaqueductal grey in limbic and neocortical vocal fold control. Neuroreport 1996;25:2921-2923
83. Larson C. The midbrain periaqueductal gray: a brainstem structure involved in vocalization. J Speech Hear Res 1985;28:241-249
84. MacLean PD, Newman JD. Role of midline frontolimbic cortex in production of the isolation call of squirrel monkeys. Brain Res 1988;450:111-123
85. Muller-Preuss P, Newnan J, Jurgens U. Anatomical and physiological evidence for a relationship between the "cingular" vocalization area and the auditory cortex in the squirrel monkey. Brain Res 1980;202:307-315
86. Ploog D. Phonation, emotion, cognition, with reference to the brain mechanisms involved. Ciba Found Symp 1979;69:79-98
87. West RA, Larson CR. Neurons of the anterior mesial cortex related to faciovocal activity in the awake monkey. J Neurophysiol 1995;74:1856-1869
88. Sapir S, Campbell C, Larson C. Effect of geniohyoid, cricothyroid, and sternothyroid muscle stimulation on voice fundamental frequency of electrically elicited phonation in rhesus macaque. Laryngoscope 1981;91:457-468
89. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002;25:295-301
90. Kleim J, Jones T, Schallert T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res 2003;11:1757-1769
91. Vaynman S, Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabil Neural Repair 2005;19:283-295
92. Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem 2003;85: 299-305
93. Neeper SA, Gomez-Pinilla F, Choi J, Cotman C. Exercise and brain neurotrophins. Nature 1995; 373:109
94. Ying Z, Roy RR, Edgerton R, Gomez-Pinilla F. Exercise restores levels of neurotrophins and synaptic plasticity following spinal cord injury. Exp Neurol 2005;193(2):411-419
95. Kleim J, Jones T. Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. Presented at: the Neurorehabilitation Workgroup Innovation and Evolution Workshop; April 2005, Gainesville, FL
96. Robichaud JA, Pfann KD, Vaillancourt DE, Comella CL, Corcos DM. Force control and disease severity in Parkinson's disease. Mov Disord 2005;20:441-450
97. Pisani A, Centonze D, Bernardi G, Calabresi P. Straital synaptic plasticity: implications for motor learning and Parkinson's disease. Mov Disord 2005;20(4):395-402
98. Kleim JA, Hogg TM, VanderBerg PM, Cooper NR, Bruneau R, Remple M. Cortical synaptogenesis and motor map reorganization occur during late, but not early, phase of motor skill learning. J Neurosci 2004;24(3):628-633
99. Ramig LO, Pawlas A, Countryman S. The Lee Silverman Voice Treatment (LSVT): A practical guide to treating the voice and speech disorders in Parkinson disease. Iowa City, IA: National Center for Voice and Speech; 1995
100. Comery TA, Shar R, Greenough WT. Differential rearing alters spine density on medium-sized spiny neurons in the rat corpus striatum: evidence for association of morphological plasticity with early response gene expression. Neurobiol Learn Mem 1995;63:217-219
101. Kleim JA, Lussnig E, Schwarz ER, Comery TA, Greenough WT. Synaptogenesis and Fos expression in the motor cortex of the adult rat after motor skill learning. J Neurosci 1996;16:4529-4535
102. Plautz EJ, Milliken GW, Nudo RJ. Effects of repetitive motor training on movement representations in adult squirrel monkeys: role of use versus learning. Neurobiol Learn Mem 2000; 74:27-55
103. Becker G, Mueller A, Braune S, et al. Early diagnosis of Parkinson's disease. J Neurol 2002; 249(Suppl 3):40-48
104. O'Shea S, Morris ME, Iansek R. Dual task interference during gait in people with Parkinson disease: effects of motor versus cognitive secondary tasks. Phys Ther 2002;82(9):888-897
105. Fox CM, Morrison CE, Ramig LO, Sapir S. Current perspectives on the Lee Silverman Voice Treatment (LSVT) for people with idiopathic Parkinson's disease. Am J Speech Lang Pathol 2002;11:111-123
106. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13: 266-271
107. Graybiel AM. The basal ganglia and chunking of action repertoires. Neurobiol Learn Mem 1998; 70:119-136
108. Jones TA, Chu CJ, Grande LA, Gregory AD. Motor skills training enhances lesion-induced structural plasticity in the motor cortex of adult rats. J Neurosci 1999;19(22):10153-10163
109. Tillerson J, Cohen A, Caudle M, Zigmond M, Schallert T, Miller G. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci 2002;22(15):6790-6799
110. Fox C, Ramig L. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. Am J Speech Lang Pathol 1997;6:85-94
111. Sapir S, Ramig LO, Hoyt P, Countryman S, O'Brien C, Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment. Folia Phoniatr Logop 2002;54:296-303
112. Byl N, Merzenich MM, Jenkins WM. A primate genesis model of focal dystonia and repetitive strain injury: I. Learning-induced dedifferentiation of the representation of the hand in the primary somatosensory cortex in adult monkeys. Neurology 1996;47:508-520
113. Lenz PA, Byl NN. Reorganization in the cutaneous core of the human thalamic principal somatic sensory nucleus (ventral caudal) in patients with dystonia. J Neurophysiol 1999;82:3204-3212
114. Byl NN, McKenzie A. Treatment effectiveness for patients with a history of repetitive hand use of and focal hand dystonia: a planned, prospective follow-up. J Hand Ther 2000;13:289-301
115. Brizard M, Carcenac C, Bemelmans AP, Feuerstein C, Mallet J, Savasta M. Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease. Neurobiol Dis 2006;21(1):90-101
116. Faherty CJ, Shepherd KR, Herasimtschuk A. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Brain Res Mol Brain Res 2005;134: 170-179
117. Tillerson J, Cohen A, Philhower J, Miller G, Zigmond M, Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 2001;21(12): 4427-4435
118. Tillerson JL, Caudle WM, Reveron ME, Miller GW. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 2003; 119:899-911
119. Bezard E, Gross C. Compensatory mechanisms in experimental and human Parkinsonism: Towards a dynamic approach. Prog Neurobiol 1998;55:93-116
120. Poulton NP, Muir GD. Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-Parkinsonian rats. Exp Neurol 2005;193:181-197
121. Taub E. Harnessing brain plasticity through behavioral techniques to produce new treatments in neurorehabilitation. Am Psychol 2004;59:692-704
122. Fisher B, Yip J. Physical Therapy for Individuals with Parkinson's Disease: A Paradigm Shift. Miami, FL: National Parkinson Foundation, Parkinson Report; 2004:10-13
123. Taub E, Lum PS, Hardin P, Mark BW, Uswatte G. AutoCITE: automated delivery of CI therapy with reduced effort by therapists. Stroke 2005; 36:1301-1304
124. Halpern AE, Matos C, Ramig LO, Petska J, Spielman J. LSVTC - A PDA Supported Speech Treatment for Parkinson's disease. Poster presented at: the Annual American Speech-Language-Hearing Association Meeting; 2004, Philadelphia, PA
125. Halpern A, Matos C, Ramig L, Petska J, Spielman J, Bennett J. LSVTC - A PDA supported speech treatment for Parkinson's disease. Presented at: the 9th International Congress of Parkinson's Disease and Movement Disorders; 2005, New Orleans, LA
126. Halpern A, Cole R, Ramig L, et al. Virtual speech therapists - expanding the horizons of speech treatment for Parkinson's disease. Paper presented at: the Conference on Motor Speech; March 2006
127. Brown RG, Maiden CD. Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain 1991; 114:215-231
128. Theodoros DG, Constantinescu G, Russell T, Ward EC, Woolen R. A telerehabilitation application for treating disordered speech in Parkinson's disease. Paper presented at: The American Telemedicine Association Conference, May 7-10, 2006